Patents by Inventor Takahiro YAMAMURA

Takahiro YAMAMURA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230105990
    Abstract: An improved solubility of a pharmaceutical composition or formulation containing a large amount of 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile or a salt thereof can be achieved by forming granules of the compound or salt thereof and allowing the granules to be present together with a disintegrating agent.
    Type: Application
    Filed: August 26, 2022
    Publication date: April 6, 2023
    Applicant: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Takashi TOMIMATSU, Kensuke OKAZAKI, Yumi OGAWA, Takahiro YAMAMURA
  • Publication number: 20220378800
    Abstract: An improved solubility of a pharmaceutical composition or formulation containing a large amount of 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile or a salt thereof can be achieved by forming granules of the compound or salt thereof and allowing the granules to be present together with a disintegrating agent.
    Type: Application
    Filed: July 29, 2022
    Publication date: December 1, 2022
    Applicant: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Takashi TOMIMATSU, Kensuke OKAZAKI, Yumi OGAWA, Takahiro YAMAMURA
  • Patent number: 11433076
    Abstract: An improved solubility of a pharmaceutical composition or formulation containing a large amount of 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile or a salt thereof can be achieved by forming granules of the compound or salt thereof and allowing the granules to be present together with a disintegrating agent.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: September 6, 2022
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Takashi Tomimatsu, Kensuke Okazaki, Yumi Ogawa, Takahiro Yamamura
  • Publication number: 20200038407
    Abstract: An improved solubility of a pharmaceutical composition or formulation containing a large amount of 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile or a salt thereof can be achieved by forming granules of the compound or salt thereof and allowing the granules to be present together with a disintegrating agent.
    Type: Application
    Filed: July 11, 2019
    Publication date: February 6, 2020
    Applicant: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Takashi TOMIMATSU, Kensuke OKAZAKI, Yumi OGAWA, Takahiro YAMAMURA
  • Patent number: 10350214
    Abstract: An improved solubility of a pharmaceutical composition or formulation containing a large amount of 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile or a salt thereof can be achieved by forming granules of the compound or salt thereof and allowing the granules to be present together with a disintegrating agent.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: July 16, 2019
    Assignee: CHUGAI SEIYAKU KABUSHIKI KAISHA
    Inventors: Takashi Tomimatsu, Kensuke Okazaki, Yumi Ogawa, Takahiro Yamamura
  • Publication number: 20170035773
    Abstract: An improved solubility of a pharmaceutical composition or formulation containing a large amount of 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile or a salt thereof can be achieved by forming granules of the compound or salt thereof and allowing the granules to be present together with a disintegrating agent.
    Type: Application
    Filed: April 24, 2015
    Publication date: February 9, 2017
    Applicant: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Takashi Tomimatsu, Kensuke OKAZAKI, Yumi OGAWA, Takahiro YAMAMURA